Página principal > Resultados de la búsqueda: wiseman
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Resultados globales: 3 registros encontrados en 0.02 segundos.
Artículos, Encontrados 3 registros
Artículos Encontrados 3 registros  
1.
13 p, 965.1 KB Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries / Tack, Jan (University of Leuven) ; Stanghellini, Vincenzo (University Hospital S.Orsola) ; Mearin, Fermín 1956- (Centro Médico Teknon) ; Yiannakou, Yan (County Durham and Darlington NHS Trust) ; Layer, Peter (Israelitic Hospital) ; Coffin, Benoit (Paris Diderot University) ; Simren, Magnus (Sahlgrenska University Hospital (Suècia)) ; Mackinnon, Jonathan (TFS Develop S.L) ; Wiseman, Gwen (Allergan International) ; Marciniak, Anne (Allergan International) ; Brotons, Carlos (Institut d'Investigació Biomèdica Sant Pau) ; Universitat Autònoma de Barcelona
Irritable bowel syndrome with predominant constipation (IBS-C) is a complex disorder with gastrointestinal and nervous system components. The study aim was to assess the economic burden of moderate to severe IBS-C in six European countries (France, Germany, Italy, Spain, Sweden and the UK). [...]
2019 - 10.1186/s12876-019-0985-1
BMC Gastroenterology, Vol. 19 Núm. 1 (july 2019) , p. 69  
Registro completo - Creative Commons
2.
12 p, 1.2 MB Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease / Startin, Carla M. (LonDownS Consortium (London Down Syndrome Consortium)) ; Ashton, Nicholas J. (University of Gothenburg) ; Hamburg, Sarah (LonDownS Consortium (London Down Syndrome Consortium)) ; Hithersay, Rosalyn (LonDownS Consortium (London Down Syndrome Consortium)) ; Wiseman, Frances K. (University College London) ; Mok, Kin Y. (Hong Kong University of Science and Technology) ; Hardy, John (University College London) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Lovestone, Simon (University of Oxford) ; Parnetti, Lucilla (University of Perugia) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Hye, Abdul (Maudsley NHS Foundation) ; Fisher, Elisabeth ; Nizetic, Dean ; Tybulewicz, Victor ; Karmiloff-Smith, Anette ; Al-Janabi, Tamara ; Zhang, David ; Strydom, André (LonDownS Consortium (London Down Syndrome Consortium)) ; Universitat Autònoma de Barcelona
Down syndrome (DS), caused by chromosome 21 trisomy, is associated with an ultra-high risk of dementia due to Alzheimer's disease (AD), driven by amyloid precursor protein (APP) gene triplication. Understanding relevant molecular differences between those with DS, those with sporadic AD (sAD) without DS, and controls will aid in understanding AD development in DS. [...]
2019 - 10.1186/s13195-019-0477-0
Alzheimer's research & therapy, Vol. 11 Núm. 1 (21 2019) , p. 26  
Registro completo - Creative Commons
3.
15 p, 1.6 MB The ABNL-MARRO 001 study : a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes / Moyo, Tamara K. (Vanderbilt University School of Medicine) ; Mendler, Jason H (University of Rochester Medical Center) ; Itzykson, Raphael (Paris Diderot University) ; Kishtagari, Ashwin (Vanderbilt University School of Medicine) ; Solary, Eric (Institut Gustave Roussy. Université Paris-Saclay) ; Seegmiller, Adam C. (Vanderbilt University School of Medicine) ; Gerds, Aaron T. (Cleveland Clinic) ; Ayers, Gregory D. (Vanderbilt University School of Medicine) ; Dezern, Amy E. (Johns Hopkins University) ; Nazha, Aziz (Cleveland Clinic) ; Valent, Peter (Ludwig Boltzmann Institute for Hematology and Oncology. Medical University of Vienna) ; Onida, Francesco (University of Milan) ; Van Azizan de Loosdrecht, Arjan A. (Amsterdam UMC. University Medical Center) ; Pleyer, Lisa (Salzburg Cancer Research Institute Center for Clinical Cancer and Immunology Trials) ; Xicoy Cirici, Blanca (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Tibes, Raoul (Mayo Clinic) ; Geissler, Klaus (Sigmund Freud University) ; Komrokji, Rami S. (H. Lee Moffitt Cancer Center) ; Zhang, Jing (University of Wisconsin-Madison) ; Germing, Ulrich (Department of Hematology. Oncology. and Clinical Immunology. University of Duesseldorf) ; Steensma, David P. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Wiseman, Daniel H. (University of Manchester) ; Pfeilstöecker, Michael (Hanusch Hospital and Ludwig Boltzmann Institute for Hematology and Oncology) ; Elena, Chiara (University of Pavia) ; Cross, Nicholas C P (University of Southampton) ; Luebbert, Michael (University of Freiburg) ; Mesa, Ruben A. (Mays Cancer Center at UT Health San Antonio MD Anderson) ; Montalban-Bravo, Guillermo (MD Anderson Cancer Center) ; Sanz, G.F. (Hospital Universitari i Politècnic La Fe (València)) ; Platzbecker, Uwe (University Hospital Leipzig) ; Patnaik, Mrinal M. (Mayo Clinic) ; Padron, Eric (H. Lee Moffitt Cancer Center) ; Santini, Valeria (University of Florence) ; Fenaux, Pierre (Paris Diderot University) ; Savona, Michael R. (Vanderbilt University School of Medicine) ; Universitat Autònoma de Barcelona
Background: Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) comprise several rare hematologic malignancies with shared concomitant dysplastic and proliferative clinicopathologic features of bone marrow failure and propensity of acute leukemic transformation, and have significant impact on patient quality of life. [...]
2022 - 10.1186/s12885-022-10073-w
BMC Cancer, Vol. 22 Núm. 1 (december 2022) , p. 1013  
Registro completo - Creative Commons

¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos